• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β1 的高表达预测颅底脊索瘤的肿瘤进展。

High Expression of TGF-β1 Predicting Tumor Progression in Skull Base Chordomas.

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Brian Tumor, Beijing, China.

Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

出版信息

World Neurosurg. 2019 Nov;131:e265-e270. doi: 10.1016/j.wneu.2019.07.128. Epub 2019 Jul 23.

DOI:10.1016/j.wneu.2019.07.128
PMID:31349076
Abstract

OBJECTIVE

To investigate the expression characteristics and prognostic value of transforming growth factor β1 (TGF-β1) in primary skull base chordomas (SBCs).

METHODS

The mRNA expression levels of TGF-β1 were measured in 57 frozen samples from patients with primary SBCs. Clinical data collection, follow-up, correlations, and survival analyses were performed.

RESULTS

In the series of 57 patients (29 men and 28 women) with primary SBCs, the mean value of TGF-β1 mRNA was 1.713 with a median of 0.904. Twenty-four SBCs were soft type and 33 were hard type. The Mann-Whitney U test revealed that the expression level of TGF-β1 mRNA in hard type SBCs was significantly higher than the expression level found in the soft type (P = 0.03). The independent-samples median test suggested that the expression level of TGF-β1 mRNA in female patients' SBCs was significantly higher than that in male patients' SBCs (P = 0.01). Expression differences of TGF-β1 were not seen among different pathological subtypes, tumor blood supply, or degree of resection. The Spearman rank correlation coefficient clarified that TGF-β1 mRNA levels were not correlated with tumor diameter, preoperative Karnofsky Performance Status (KPS), postoperative KPS, follow-up KPS, age, or intraoperative blood loss. The multivariate Cox analysis revealed that pathological subtype (P = 0.008), expression level of TGF-β1 mRNA (P = 0.01), and tumor texture (P = 0.03) were all independent prognostic factors for tumor progression.

CONCLUSIONS

SBCs in female patients and SBCs with hard texture were prone to have high TGF-β1 mRNA expression. High expression of TGF-β1, hard tumor texture, and conventional subtype were all independent risk factors for tumor progression.

摘要

目的

研究转化生长因子β1(TGF-β1)在原发性颅底脊索瘤(SBC)中的表达特征及其预后价值。

方法

对 57 例原发性 SBC 患者的 57 例冷冻标本进行 TGF-β1mRNA 表达水平的检测。进行临床资料收集、随访、相关性和生存分析。

结果

在 57 例(29 名男性和 28 名女性)原发性 SBC 患者中,TGF-β1mRNA 的平均值为 1.713,中位数为 0.904。24 例 SBC 为软型,33 例为硬型。Mann-Whitney U 检验显示,硬型 SBC 中 TGF-β1mRNA 的表达水平明显高于软型(P=0.03)。独立样本中位数检验表明,女性患者 SBC 中 TGF-β1mRNA 的表达水平明显高于男性患者(P=0.01)。TGF-β1 的表达差异与不同的病理亚型、肿瘤血供或切除程度无关。Spearman 秩相关系数表明,TGF-β1mRNA 水平与肿瘤直径、术前卡诺夫斯基表现状态(KPS)、术后 KPS、随访 KPS、年龄或术中失血量均无相关性。多变量 Cox 分析表明,病理亚型(P=0.008)、TGF-β1mRNA 表达水平(P=0.01)和肿瘤质地(P=0.03)均为肿瘤进展的独立预后因素。

结论

女性患者的 SBC 和质地坚硬的 SBC 更易出现 TGF-β1mRNA 高表达。TGF-β1 高表达、肿瘤质地坚硬和常规亚型均为肿瘤进展的独立危险因素。

相似文献

1
High Expression of TGF-β1 Predicting Tumor Progression in Skull Base Chordomas.TGF-β1 的高表达预测颅底脊索瘤的肿瘤进展。
World Neurosurg. 2019 Nov;131:e265-e270. doi: 10.1016/j.wneu.2019.07.128. Epub 2019 Jul 23.
2
High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.Survivin 的高表达与颅底脊索瘤患者的肿瘤进展和死亡率独立相关。
J Neurosurg. 2020 Jan 1;132(1):140-149. doi: 10.3171/2018.8.JNS181580. Epub 2019 Jan 11.
3
Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors.颅底脊索瘤:45 例连续病例的长期随访结果和临床及生物学预后因素的评估
J Neurosurg. 2016 Aug;125(2):450-60. doi: 10.3171/2015.6.JNS142370. Epub 2016 Jan 8.
4
A Comparative Study Between Traditional Microscopic Surgeries and Endoscopic Endonasal Surgery for Skull Base Chordomas.颅底脊索瘤的传统显微镜手术与经鼻内镜手术的对比研究。
World Neurosurg. 2020 Feb;134:e1099-e1107. doi: 10.1016/j.wneu.2019.11.113. Epub 2019 Nov 27.
5
Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.转化生长因子-α和 Ki-67 对颅底脊索瘤预后的预测价值。
World Neurosurg. 2019 Sep;129:e199-e206. doi: 10.1016/j.wneu.2019.05.110. Epub 2019 May 21.
6
Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability.颅底和非颅底脊索瘤:临床病理及免疫组织化学研究,特别关注核多形性和增殖能力
Cancer. 2003 Nov 1;98(9):1934-41. doi: 10.1002/cncr.11756.
7
Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.患者颅底脊索瘤的临床特征和手术结果:238 例回顾性分析。
J Neurosurg. 2017 Dec;127(6):1257-1267. doi: 10.3171/2016.9.JNS16559. Epub 2017 Jan 6.
8
Chordoma of the skull base: predictors of tumor recurrence.颅底脊索瘤:肿瘤复发的预测因素
J Neurosurg. 2003 Apr;98(4):812-22. doi: 10.3171/jns.2003.98.4.0812.
9
Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.颅底脊索瘤复发的分子和临床危险因素:2p 染色体获得、brachyury 表达和未接受放疗与患者预后呈负相关。
J Neuropathol Exp Neurol. 2013 Sep;72(9):816-23. doi: 10.1097/NEN.0b013e3182a065d0.
10
Male sex as a risk factor for the clinical course of skull base chordomas.男性作为颅底脊索瘤临床病程的一个风险因素。
J Neurosurg. 2014 Jun;120(6):1313-20. doi: 10.3171/2013.11.JNS131137. Epub 2014 Jan 3.

引用本文的文献

1
Radiogenomic method combining DNA methylation profiles and magnetic resonance imaging radiomics predicts patient prognosis in skull base chordoma.结合DNA甲基化图谱和磁共振成像放射组学的放射基因组学方法可预测颅底脊索瘤患者的预后。
Clin Epigenetics. 2025 Feb 17;17(1):23. doi: 10.1186/s13148-025-01836-w.
2
The novel developed and validated multiparametric MRI-based fusion radiomic and clinicoradiomic models predict the postoperative progression of primary skull base chordoma.基于多参数 MRI 的融合放射组学和临床放射组学模型预测原发性颅底脊索瘤术后进展的新型模型的建立和验证。
Sci Rep. 2024 Nov 20;14(1):28752. doi: 10.1038/s41598-024-80410-5.
3
Immune microenvironment and immunotherapy for chordoma.
脊索瘤的免疫微环境与免疫治疗
Front Oncol. 2024 Jun 24;14:1374249. doi: 10.3389/fonc.2024.1374249. eCollection 2024.
4
Chordoma cells possess bone-dissolving activity at the bone invasion front.脊索瘤细胞在骨侵袭前沿具有溶骨性活性。
Cell Oncol (Dordr). 2024 Oct;47(5):1663-1677. doi: 10.1007/s13402-024-00946-6. Epub 2024 Apr 23.
5
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma.单细胞测序揭示 VEGFR 是软骨肉瘤 CAR-T 细胞治疗的潜在靶点。
Br J Cancer. 2024 Jun;130(10):1609-1620. doi: 10.1038/s41416-024-02635-5. Epub 2024 Apr 11.
6
Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma Regulating the Hippo Signaling Pathway by Targeting STK25.外泌体miR-4800-3p通过靶向STK25调控Hippo信号通路加重肝细胞癌进展
Front Oncol. 2022 Jun 8;12:759864. doi: 10.3389/fonc.2022.759864. eCollection 2022.
7
MicroRNA-29b participates in the epithelial-mesenchymal transition of retinal pigment epithelial cells through p-p65.微小RNA-29b通过磷酸化的p65参与视网膜色素上皮细胞的上皮-间质转化。
Exp Ther Med. 2021 Aug;22(2):868. doi: 10.3892/etm.2021.10300. Epub 2021 Jun 13.
8
Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients.全身免疫炎症指数和预后营养指数在颅底脊索瘤患者中的临床意义
Front Oncol. 2021 Feb 25;11:548325. doi: 10.3389/fonc.2021.548325. eCollection 2021.
9
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.T-LAK 细胞源蛋白激酶(TOPK)是软骨肉瘤的一个新的预后和治疗靶点。
Cell Prolif. 2020 Oct;53(10):e12901. doi: 10.1111/cpr.12901. Epub 2020 Sep 22.